Welcome to a CDMO where science meets service excellence, where innovation merges with reliability
Revolutionise your clinical development with our expert development & manufacturing services for innovative biomolecules
We support your project from R&D to in-market supply
Start your CMC journey confidently with our tailored development and GMP manufacturing services
R&D services
Custom production services with all prominent expression systems providing recombinant proteins for your R&D studies.
Process Development
Developing top-tier manufacturing processes for a range of molecules: proteins, antibodies, bioconjugates, and nanodrugs.
Analytical Development
Phase-appropriate method development for mammalian, microbial, and bioconjugate manufacturing.
GMP Manufacturing
Our top-notch GMP facilities manufacture preclinical, clinical, and small commercial batches of innovative therapies.
Fill & Finish
Our in-house aseptic filling supports liquid drug product manufacturing, accelerating your path to clinic and market.
Project Management
From start to finish, our expert team of scientists guides you seamlessly through every step of your CMC journey.
Client stories: what they were looking for in a CDMO
We’ve helped our customers develop and manufacture innovative therapies for more than 20 years.
“The team at BrainEver really valued working with GTP Bioways. They quickly captured our needs and came back with suitable solutions that fit our tight timelines. Their experience in protein production was, without question, a strong asset in moving from academia research into the inital development phases.”
Hubert Mechain, BrainEver
“With GTP Bioways, Osivax found a reliable GMP-compliant formulation and aspetic filling service provider. Their understanding of our needs, commitment to quality and customer-oriented focus were appreciated. They are also our partners for some R&D and analytical activities with relevant and problem-solving scientific discussions”
Imène Turki, Osivax
“We are happy to work with GTP Bioways for our very first clinical trial. This collaboration is a key point in the preparation of our clinical product before its administration to patients. With their brand-new facilities in Toulouse and their aseptic fill and finish operations, GTP Bioways shows all the guarantees requested for our lead anticancer compound ABD-3001 during our first-in-human clinical trial in acute myeloid leukemia upcoming soon. During the set-up of our GMP production, GTP Bioways team has been quite flexible and reactive to our needs “
Ismail Ceylan, Founder and CEO of Advanced Biodesign
“At European Vaccine Initiative, we have found GTP Bioways to be a very reliable partner. I specifically appreciated the intelligence their team put in the process development, going beyond merely executing our instructions.”
Nicolas Havelange, EVI
“GTP Bioways is a flexible and reactive company with an high understanding of the development challenges for a biotech. Collaboration is easy, the teams are open to scientific discussions and collaborate with us about how to solve problems together. Very good partner for the development of new projects!”
Judith Greciet, Onxeo
“GTP Bioways is technically sound and client-oriented. We appreciated the mutual understanding between GTP Bioways and Xenothera and how GTP Bioways could adapt its offer to our needs.”
Bernard Vanhove, Xenothera
From R&D to commercial production: our expertise spans all stages of biotherapeutics development
Years as a CDMO
Years' expertise in aseptic filling
Clients served worldwide
Protein programmes managed
GTP Bioways – your partner for biologics development and manufacturing
Our process development and manufacturing facilities sit in the heart of Europe.
Saint-Julien
mAb & ADC GMP Manufacturing
Toulouse
Cell Line Development, GMP Manufacturing & Fill & Finish
Labège
Microbial & Mammalian Process Development
Veyre-Monton
HCP Risk Management & Immunoassays Development
White paper
A Guide to Smooth CDMO Tech Transfer
The key parameters to be considered while choosing your next CDMO, as well as our tips to assess those parameters, and more!
From our blog:Our biologics CDMO experience
Interview – Challenges in the Development & Manufacturing of ADCs
Simone Seechi, R&D Process Chemist at Olon and Matthieu Culié, Head of Development & GMP Manufacturing at GTP Bioways were interviewed by Citeline Clinical about the challenges in the...
Choosing a Biologics CDMO: Your Blueprint for Success
In the dynamic and high-stakes world of biologics, selecting the right Contract Development and Manufacturing Organisation (CDMO) can make or break your project. Imagine you’re about to launch a...
Effective Strategies for Host Cell Protein Purification: A Case Study
In the field of biomanufacturing, the challenge of host cell protein (HCP) purification remains a critical hurdle in many biotherapeutic development programmes. Achieving low HCP levels is paramount...
